1. Jennett B, Teasdale G. Management of Head Injuries. Philadelphia: FA Davis Co, 1981:271.

2. Temkin NR, Dikmen SS, Wilensky AJ, et al. A randomized double-blind study of phenytoin for the prevention of post-traumatic seizures. N Engl J Med 1990;323:497–502.

3. Caveness WF. Epilepsy, a product of trauma in our time. Epilepsia 1976;17:207–215.

4. Weiss GH, Feeney DM, Caveness WF, et al. Prognostic factors for the occurrence of posttraumatic epilepsy. Arch Neurol 1983;40:7–10.

5. Weiss GH, Salazar AM, Vance SC, et al. Predicting posttraumatic epilepsy in penetrating head injury. Arch Neurol 1986;43:771–773.

6. Annegers JF, Hauser WA, Coan SP, Rocca WA. A population-based study of seizures after traumatic brain injuries. N Engl J Med 1998;338:20–24.

7. Feeney DM, Walker AE. The prediction of posttraumatic epilepsy. A mathematical approach. Arch Neurol 1979;36:8–12.

8. Salazar AM, Jabbari B, Vance SC, et al. Epilepsy after penetrating head injury. I. Clinical correlates: a report of the Vietnam Head Injury study. Neurology 1985;35:1406–1414.

9. Jennett B. Epilepsy and acute traumatic intracranial haematoma. J Neurol Neurosurg Psychiatry 1975;38:378–381.

10. Kaplan HA. Management of craniocerebral trauma and its relation to subsequent seizures. Epilepsia 1961;2:111–116.

11. DeCarolis P, D’Alessandro R, Ferrara R, et al. Late seizures in patients with internal carotid and middle cerebral artery occlusive disease following ischaemic events. J Neurol Neurosurg Psychiatry 1984;47:1345–1347.

12. Richardson EP, Dodge PR. Epilepsy in cerebrovascular disease. Epilepsia 1954;3:49–74.

13. Faught E, Peters D, Bartolucci A, et al. Seizures after primary intracerebral hemorrhage. Neurology 1989;39:1089–1093.

14. Aisen P. Some Physicochemical Aspects of Iron Metabolism. In Ciba Foundation Symposium (51st ed). New York: Elsevier, 1977:1–14.

15. Levitt P, Wilson WP, Wilkins RH. The effects of subarachnoid blood on the electrocorticogram of the cat. J Neurosurg 1971;35:185–191.

16. Willmore LJ, Sypert GW, Munson JB. Recurrent seizures induced by cortical iron injection: a model of post-traumatic epilepsy. Ann Neurol 1978;4:329–336.

17. Annegers JF, Grabow JD, Grover RV, et al. Seizures after head trauma: a population study. Neurology 1980;30:683–689.

18. Bontke CF, Lehmkuhl LD, Englander J, et al. Medical complications and associated injuries of patients treated in TBI Model System programs. J Head Trauma Rehabil 1993;8(2):34–46.

19. Kalisky Z, Morrison P, Meyers CA, Von Laufen AV. Medical problems encountered during rehabilitation of patients with head injury. Arch Phys Med Rehabil 1985;66:25–29.

20. Sazbon L, Groswasser Z. Outcome in 134 patients with prolonged posttraumatic unawareness. Part 1: parameters determining late recovery of consciousness. J Neurosurg 1990;72:75–80.

21. Ascroft PB. Traumatic epilepsy after gunshot wounds of the head. BMJ 1941;1:739–744.

22. Caveness WF, Liss HR. Incidence of post-traumatic epilepsy. Epilepsia 1961;2:123–129.

23. Caveness WF, Meirowsky AM, Rish BL, et al. The nature of posttraumatic epilepsy. J Neurosurg 1979;50:545–553.

24. Devinsky O. Epilepsy after minor head trauma. J Epilepsy 1996;9:94–97.

25. da Silva AM, Vaz AR, Riberiro I, et al. Controversies in posttraumatic epilepsy. Acta Neurochir (Wien) 1990;50:48–51.

26. Walker AE. Posttraumatic epilepsy in World War II veterans. Surg Neurol 1989;32:235–236.

27. Walker AE, Blumer D. The fate of World War II veterans with posttraumatic seizures. Arch Neurol 1989;46:23–26.

28. Walker AE, Jablon S. A follow-up of head injured men of World War II. J Neurosurg 1959;16:600–610.

29. Jennett WB, Lewin W. Traumatic epilepsy after closed head injuries. J Neurol Neurosurg Psychiatry 1960;23:295–301.

30. Walker AE, Erculei F. Posttraumatic epilepsy 15 years later. Epilepsia 1970;11:17–26.

31. Westbrook LE, Devinsky O, Geocadin B. Nonepileptic seizures after head injury. Epilepsia 1998;39:978–982.

32. Falconer MA, Serafetinides EA, Corsellis JA. Etiology and pathogenesis of temporal lobe epilepsy. Arch Neurol 1964;10:233–248.

33. Betz P, Eisenmenger W. Traumatic origin of a meningioma? Int J Legal Med 1995;107:326–328.

34. Mathern GW, Babb TL, Armstrong DL. Hippocampal Sclerosis. In J Engel Jr, TA Pedley (eds), Epilepsy: a Comprehensive Textbook. Philadelphia: Lippincott–Raven, 1997:133–155.

35. Cascino GD, Jack CR, Parisi JE, et al. Operative strategy in patients with MRI-identified dual pathology and temporal lobe epilepsy. Epilepsy Res 1993;33:639–644.

36. Li LM, Cendes F, Watson C, et al. Surgical treatment of patients with single and dual pathology: relevance of lesion and of hippocampal atrophy to seizure outcome. Neurology 1997;48:437–444.

37. Lowenstein DH, Thomas MJ, Smith DH, McIntosh TK. Selective vulnerability of dentate hilar neurons following traumatic brain injury: a potential mechanistic link between head trauma and disorders of the hippocampus. J Neurosci 1992;12:4846–4853.

38. Lingren SO. Experimental studies of mechanical effects in head injury. Acta Chir Scand 1966;132[Suppl 360]:1–32.

39. Willmore LJ. Prophylactic Use of Anticonvulsant Drugs. In SR Resor Jr, H Kutt (eds), Medical Treatment of Epilepsy. New York: Dekker, 1992:73–77.

40. Rapport RL, Penry JK. Pharmacologic prophylaxis of post-traumatic epilepsy: a review. Epilepsia 1972;13:295–304.

41. Young B, Rapp R, Brooks WH, et al. Post-traumatic epilepsy prophylaxis. Epilepsia 1979;20:671–681.

42. Rish BL, Caveness WF. Relation of prophylactic medication to the occurrence of early seizures following craniocerebral trauma. J Neurosurg 1973;38:155–158.

43. Wohns RN, Wyler AR. Prophylactic phenytoin in severe head injuries. J Neurosurg 1979;51:507–509.

44. Penry JK, White BG, Brackett CE. A controlled prospective study of the pharmacologic prophylaxis of posttraumatic epilepsy. Neurology 1979;29:600–601.

45. Young B, Rapp RP, Norton JA, et al. Failure of prophylactically administered phenytoin to prevent late post- traumatic seizures. J Neurosurg 1983;58:236–241.

46. Haltiner AM, Newell DW, Temkin NR, et al. Side effects and mortality associated with use of phenytoin for early posttraumatic seizure prophylaxis. J Neurosurg 1999;91:588–592.

47. Silver JM, Shin C, McNamara JO. Antiepileptogenic effects of conventional anticonvulsants in the kindling model of epilepsy. Ann Neurol 1991;29:356–363.

48. Temkin NR, Dikmen SS, Anderson GD, et al. Valproate therapy for prevention of posttraumatic seizures: a randomized trial. J Neurosurg 1999;91:593–600.

49. Pudenz RH, Shelden CH. The lucite calvarium—a method for direct observation of the brain. J Neurosurg 1946;3:487–505.

50. Gennarelli TA, Thibaulat LE, Adams JH, et al. Diffuse axonal injury and traumatic coma in the primate. Ann Neurol 1982;12:564–574.

51. Langfitt TW, Weinstein JD, Kassell NF. Vascular Factors in Head Injury. Contribution to Brain-Swelling and Intracranial Hypertension. In WE Caveness, AE Walker (eds), Head Injury. Philadelphia: Lippincott, 1966:172–194.

52. Tornheim PA, Liwnicz BH, Hirsch CS, et al. Acute responses to blunt head trauma. J Neurosurg 1983;59:431–438.

53. Unterharnscheidt F, Sellier K. Mechanisms and pathomorphology of closed head injuries. In WF Caveness, AE Walker (eds), Head Injury. Philadelphia: Lippincott, 1966:321–341.

54. Willmore LJ. Posttraumatic epilepsy: cellular mechanisms and implications for treatment. Epilepsia 1990;31[Suppl 3]:S67–S73.

55. Payan H, Toga M, Berard-Badier M. The pathology of post-traumatic epilepsies. Epilepsia 1970;11:81–94.

56. Fong KL, McCay BP, Poyer JL, et al. Evidence that peroxidation of lysosomal membranes is initiated by hydroxyl free radicals produced during flavin enzyme activity. J Biol Chem 1973;248:7792–7797.

57. Fong KL, McCay PB, Poyer JL, et al. Evidence of superoxide-dependent reduction of Fe3+ and its role in enzyme-generated hydroxyl radical formation. Chem Biol Interact 1976;15:77–89.

58. Svingen BA, O’Neal FO, Aust SD. The role of super- oxide and singlet oxygen in lipid peroxidation. Photo- chem Photobiol 1978;28:803–809.

59. Willmore LJ, Hiramatsu M, Kochi H, Mori A. Formation of superoxide radicals, lipid peroxides, and edema after FeCl3 injection into rat isocortex. Brain Res 1983;277:393–396.

60. Czapski G, Ilan YA. On the generation of the hydroxylation agent from superoxide radical. Can the Haber- Weiss reaction be the source of OH radicals? Photo- chem Photobiol 1978;28:651–653.

61. Koppenol WH, Butler J, van Leeuwen JW. The HaberWeiss cycle. Photochem Photobiol 1978;28:655–660.

62. Aust SD, Svingen BA. The role of iron in enzymatic lipid peroxidation. In WA Pryor (ed), Free Radicals in Biology. New York: Academic, 1982:1–28.

63. Baker N, Wilson L. Water-soluble products of UV-irradiated, autoxidized linoleic and linolenic acids. J Lipid Res 1966;7:341–348.

64. Niehaus WG, Samuelsson B. Formation of malonalde- hyde from phospholipid arachidonate during microsomal lipid peroxidation. Eur J Biochem 1968;6:126–130.

65. Triggs WJ, Willmore LJ. In vivo lipid peroxidation in rat brain following intracortical Fe2+ injection. J Neurochem 1984;42:976–980.

66. Smith GJ, Dunkley WL. Initiation of lipid peroxidation by a reduced metal ion. Arch Biochem Biophys 1962;98:46–48.

67. Anderson DK, Means ED. Lipid peroxidation in spinal cord. FeCl2 induction and protection with antioxidants. Neurochem Pathol 1983;1:249–264.

68. Willmore LJ, Rubin JJ. Effects of antiperoxidants on FeCl2-induced lipid peroxidation and focal edema in rat brain. Exp Neurol 1984;83:62–70.

69. Triggs WJ, Willmore LJ. Effect of [dl]-alpha-tocopherol on FeCl2-induced lipid peroxidation in rat amygdala. Neurosci Lett 1994;180:33–36.

70. Willmore LJ, Rubin JJ. Antiperoxidant pretreatment and iron-induced epileptiform discharge in the rat: EEG and histopathologic study. Neurology 1981;31:63–69.

71. Prince DA, Connors BW. Mechanisms of epileptogenesis in cortical structures. Ann Neurol 1984;16[Suppl]:S59–S64.

72. Dichter MA, Ayala GF. Cellular mechanisms of epilepsy: a status report. Science 1987;237:157–164.

73. Saji M, Reis DJ. Delayed transneuronal death of substantia nigra neurons prevented by gamma-aminobutyric acid agonist. Science 1987;235:66–69.

74. Faden AI, Demediuk P, Panter SS, Vink R. The role of excitatory amino acids and NMDA receptors in traumatic brain injury. Science 1989;244:798–800.

75. Gall CM, Isackson PJ. Limbic seizures increase neuronal production of messenger RNA for nerve growth factor. Science 1989;245:758–761.

76. Nieto-Sampedro M. Astrocyte mitogen inhibitor related to epidermal growth factor receptor. Science 1988;240:1784–1786.

77. Green RC, Blume HW, Kupferschmid SB, Mesulam MM. Alterations of hippocampal acetylcholinesterase in human temporal lobe epilepsy. Ann Neurol 1989;26:347–351.

78. Sutula T, Cascino G, Cavazos J, et al. Mossy fiber synaptic reorganization in the epileptic human temporal lobe. Ann Neurol 1989;26:321–330.

79. Ribak CE, Harris AB, Vaughn JE, Roberts E. Inhibitory GABAergic nerve terminals decrease at sites of focal epilepsy. Science 1979;205:211–214.

80. Carlsson J, Carpenter VS. The recA+ gene product is more important than catalase and superoxide dismutase in protecting Escherichia coli against hydrogen peroxide toxicity. J Bacteriol 1980;142:319–321.

81. Imlay JA, Linn S. DNA damage and oxygen radical toxicity. Science 1988;240:1302–1309.

82. Panter SS, Sadrzadeh SM, Hallaway PE, et al. Hypohaptoglobinemia associated with familial epilepsy. J Exp Med 1985;161:748–754.

83. Gutteridge JM. The antioxidant activity of haptoglobin towards haemoglobin-stimulated lipid peroxidation. Biochim Biophys Acta 1987;917:219–223.

84. During MJ, Spencer DD. Extracellular hippocampal glutamate and spontaneous seizure in the conscious human brain. Lancet 1993;341:1607–1610.

85. Rothstein JD, Dykes-Hoberg M, Pardo CA, et al. Knockout of glutamate transporters reveals a major role for astroglial transport in excitotoxicity and clearance of glutamate. Neuron 1996;16:675–686.

86. Lehre KP, Levy LM, Ottersen OP, et al. Differential expression of two glial glutamate transporters in the rat brain: quantitative and immunocytochemical observations. J Neurosci 1995;15:1835–1853.

87. Tanaka S, Kondo S, Tanaka T, Yonemasu Y. Long-term observation of rats after unilateral intra-amygdaloid injection of kainic acid. Brain Res 1988;463:163–167.

88. Tanaka T, Tanaka S, Fujita T, et al. Experimental complex partial seizures induced by a microinjection of kainic acid into limbic structures. Prog Neurobiol 1992;38:317–334.

89. Ueda Y, Willmore LJ, Triggs WJ. Amygdalar injection of FeCl3 causes spontaneous recurrent seizures. Exp Neurol 1998;153:123–127.

90. Doi T, Ueda Y, Tokumaru J, et al. Sequential changes in glutamate transporter mRNA during Fe+++ induced epileptogenesis. Mol Brain Res 2000;75:105–112.

91. Ueda Y, Willmore LJ. Sequential changes in glutamate transporter protein levels during Fe+++ induced epileptogenesis. Epilepsy Res 2000;39:201–219.

92. Borden LA, Smith KE, Hartig PR, et al. Molecular heterogeneity of gamma-aminobutyric acid (GABA) transport system. J Biol Chem 1992;267:21098–21104.

93. Durkin MM, Smith KE, Borden LA, et al. Localization of messenger RNAs encoding three GABA transporters in rat brain: an in situ hybridization study. Mol Brain Res 1995;33:7–21.

94. Minelli A, Brecha NC, Karschin C, et al. GAT-1, a high affinity GABA plasma membrane transporter is localized to neurons and astroglia in the cerebral cortex. J Neurosci 1995;15:7734–7746.

95. Ribak CE, Tong WM, Brecha NC. GABA plasma membrane transporters. GAT-1 and GAT-2 display different distributions in the rat hippocampus. J Comp Neurol 1996;367:595–606.

96. Ueda Y, Willmore LJ. Hippocampal gamma-aminobutyric acid transporter alterations following focal epileptogenesis induced in rat amygdala. Brain Res Bull 2000;52:357–361.

97. Fridovich I. Superoxide dismutase. Adv Enzymol 1974;41:35–97.

98. Orlowski M, Karkowsky A. Glutathione metabolism and some possible functions of glutathione in the nervous system. Int Rev Neurobiol 1976;19:75–121.

99. Tappel AL. Lipid peroxidation damage to cell components. Fed Proc 1973;32:1870–1874.

100. McCay PB, King MM. Vitamin E: Its Role As a Biological Free Radical Scavenger and Its Relationship to the Microsomal Mixed-Function Oxidase System. In LJ Machlin (ed), Vitamin E. New York: Marcel Dekker, 1980;289–317.

101. Rehncrona S, Smith DS, Akesson B, et al. Peroxidative changes in brain cortical fatty acids and phospholipids, as characterized during Fe2+- and ascorbic acid-stimulated lipid peroxidation in vitro. J Neurochem 1980;34:1630–1638.

102. Tappel AL. Vitamin E and free radical peroxidation of lipids. Ann N Y Acad Sci 1972;203:12–28.

103. Witting LA. Vitamin E and Lipid Antioxidants in FreeRadical-Initiated Reactions. In WA Pryor (ed), Free Radicals in Biology (vol 4). New York: Academic, 1980;295–319.

104. Diplock AT, Lucy JA. The biochemical modes of action of vitamin E and selenium: a hypothesis. FEBS Lett 1973;29:205–210.

105. Lucy JA. Functional and structural aspects of biological membranes: a suggested structural role for vitamin E in the control of membrane permeability and stability. Ann N Y Acad Sci 1972;203:4–11.

106. Hall ED, Yonkers PA, McCall JM, Braughler JM. Effects of the 21-aminosteroid U74006F on experimental head injury in mice. J Neurosurg 1988;68:456–461.

107. Willmore LJ. Post-traumatic epilepsy: mechanisms and prevention [Review]. Psychiatry Clin Neurosci 1995;49:S171–S173.

108. Chan PH, Fishman RA. Transient formation of super- oxide radicals in polyunsaturated fatty acid-induced brain swelling. J Neurochem 1980;35:1004–1007.

109. Fishman RA, Chan PH, Lee J, Quan S. Effects of superoxide free radicals on the induction of brain edema. Neurology 1979;29:546.

110. Wagner FC, Stewart WB. Effect of trauma dose on spinal cord edema. J Neurosurg 1981;54:8802–8806.

111. Callaghan N, Garrett A, Goggin T. Withdrawal of anti- convulsant drugs in patients free of seizures for two years. N Engl J Med 1988;318:942–946.

112. Chadwick D, Reynolds EH. When do epileptic patients need treatment? Starting and stopping medication. BMJ 1985;290:1885–1888.

Reviewed By: 
Steven C. Schachter, MD
Thursday, April 1, 2004